# Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer

> **NCT03386500** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Nebraska** · enrollment: 24 (actual)

## Conditions studied

- Anal Cancer, Squamous Cell Carcinoma
- Radiation Exposure

## Interventions

- **DRUG:** BMX-001

## Key facts

- **NCT ID:** NCT03386500
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-11-28
- **Primary completion:** 2026-10
- **Final completion:** 2029-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03386500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03386500, "Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT03386500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*